Database: Additional databases on drug expenditure (France): Difference between revisions

Revision as of 18:56, 27 April 2024

Go back to France page

Primary purpose: Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts.

Sponsor, manager or home institution: Caisse Nationale de l'Assurance Maladie (CNAM) [1].

Available type of information: atc code, main anatomical group, therapeutic subgroup (drug group), pharmacological subgroup, chemical subgroup, pharmaceutical specialty identification code, generic group, age at the time of care, sex, place of residence, prescriber, costs reimbursement, number of drugs, number of patients (available only in NB_ type bases), year.

Source of Information: Système National des Données de Santé (SNDS) [2].

Available data level: regional level.

Number of Records:

Date Range: 2014 onwards.

Cancer Areas of Interest:

Data access: publicly available [3].

Contact information: Information [4].

@@ Line 1: / Line 1: @@
 {{forresearchers}}
 Go back to [[France]] page
+'''Primary purpose:''' Provides additional bases for medication expenses, enriched with beneficiary counts from all health insurance schemes in France. Offers insights into the number of people utilizing medications at various levels of grouping, along with indicators on amounts and box counts.
 '''Sponsor, manager or home institution:''' [[dataOwner::Caisse Nationale de l'Assurance Maladie (CNAM)]] [https://assurance-maladie.ameli.fr/].
-'''Type of information:''' [[availableVariable::atc code]], main anatomical group, therapeutic subgroup ([[availableVariable::drug group]]), pharmacological subgroup, chemical subgroup, pharmaceutical specialty identification code, generic group, [[availableVariable::age]] at the time of care, [[availableVariable::sex]], [[availableVariable::place of residence]], prescriber, [[availableVariable::costs reimbursement]], [[availableVariable::number of drugs]], [[availableVariable::number of patients]] (available only in NB_ type bases), [[availableVariable::year]].
+'''Available type of information:''' [[availableVariable::atc code]], main anatomical group, therapeutic subgroup ([[availableVariable::drug group]]), pharmacological subgroup, chemical subgroup, pharmaceutical specialty identification code, generic group, [[availableVariable::age]] at the time of care, [[availableVariable::sex]], [[availableVariable::place of residence]], prescriber, [[availableVariable::costs reimbursement]], [[availableVariable::number of drugs]], [[availableVariable::number of patients]] (available only in NB_ type bases), [[availableVariable::year]].
 '''Source of Information:''' Système National des Données de Santé (SNDS) [https://assurance-maladie.ameli.fr/etudes-et-donnees/presentation-systeme-national-donnees-sante-snds].
-'''Data level:''' [[availableDataLevel::regional level]].
+'''Available data level:''' [[availableDataLevel::regional level]].
+'''Number of Records:'''
+'''Date Range:''' [[dataStart::2014]] [[dataEnd::onwards]].
-'''Date Range:''' [[dataStart::2014]] - [[dataEnd::2021]].
+'''Cancer Areas of Interest:'''
 '''Data access''': [[dataAvailability::publicly available]] [https://assurance-maladie.ameli.fr/etudes-et-donnees/open-medic-depenses-beneficiaires-medicaments].
 '''Contact information:''' Information [https://assurance-maladie.ameli.fr/etudes-et-donnees/en-savoir-plus-snds/utilisation-accompagnement-donnees-snds].